LDH is present in almost all cells of the body, so its elevation indicates cell damage somewhere, without saying where.
LDH is present in almost all cells of the body, so its elevation indicates cell damage somewhere, without saying where. It is a very nonspecific test whose value lies in the context: in some specific conditions it is very useful.
Next: Hemoglobin · Platelet count · Bilirubin
One of its most useful applications. A high LDH with low haptoglobin, high indirect bilirubin and high reticulocytes defines the hemolytic pattern.
In lymphomas and leukemias LDH reflects tumor mass and is part of prognostic indices. It also rises in tumor lysis syndrome.
Myocardial infarction, intestinal infarction, pulmonary embolism and hepatitis.
Hemolysis produced during collection raises LDH artificially; it is a frequent cause of isolated, unexplained elevation.
Low values have no diagnostic relevance.
Alone it adds little. It gains value within a pattern: together with haptoglobin and bilirubin when hemolysis is suspected, or with low platelets and schistocytes when a microangiopathy is suspected, where its elevation is an alarm sign.
Because it is present in almost all cells of the body, so its elevation only indicates that there is cell damage at some point, without showing where. Its value appears when it is part of a pattern together with other tests.
When hemolysis is suspected, together with low haptoglobin, high indirect bilirubin and high reticulocytes; and as a marker of tumor mass in lymphomas and leukemias, where it is part of prognostic indices.
This page is educational material for medical training: it describes the clinical meaning of the test and the causes of its abnormalities. It is not a diagnosis or a treatment recommendation, and it does not replace the laboratory report or the individual clinical assessment, which interprets each result in its context.